![Anticonvulsants / Topiramate / Treatment of bipolar disorder / Pharmacology / Ortho-McNeil-Janssen / Ortho-McNeil Pharmaceutical / Food and Drug Administration / Pregnancy / Johnson & Johnson / Medicine / Chemistry Anticonvulsants / Topiramate / Treatment of bipolar disorder / Pharmacology / Ortho-McNeil-Janssen / Ortho-McNeil Pharmaceutical / Food and Drug Administration / Pregnancy / Johnson & Johnson / Medicine / Chemistry](https://www.pdfsearch.io/img/35185cc480775488b31145cd89c949fc.jpg) Date: 2011-03-04 17:02:38Anticonvulsants Topiramate Treatment of bipolar disorder Pharmacology Ortho-McNeil-Janssen Ortho-McNeil Pharmaceutical Food and Drug Administration Pregnancy Johnson & Johnson Medicine Chemistry | | March 4, 2011: Notice on FDA Announcement Regarding TOPAMAX® (topiramate) The Food and Drug Administration (FDA) has announced increased precautions on the use of TOPAMAX in pregnancy. As the makers of TOPAMAX, Ortho-McAdd to Reading ListSource URL: www.topamax.comDownload Document from Source Website File Size: 216,00 KBShare Document on Facebook
|